Position in BHC
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$688,859
+$433,190 QoQ
Shares Held
139,728
+279.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#74
of 220 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names. BHC ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
This page
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in BHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $688,859 | 139,728 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $255,669 | 36,787 | Shares | Sole | 2026-02-11 | |
| 2024-09-30 | $99,862 | 12,238 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $146,070 | 20,957 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $88,460 | 14,086 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $196,936 | 28,583 | Shares | Sole | 2022-11-07 | |
| 2020-12-31 | $269,672 | 12,965 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||